- April 22, 2022
- Newsletter
- 617-430-5616
Menu
Menu
Menu
Menu
Menu
Menu
Brand Name :
No Data Available.
Synonyms :
Class :
when both drugs are combined, there may be an increased effect of nilotinib by affecting hepatic or intestinal enzyme cyp3a4 metabolism
may increase the CNS depressant effect of CNS depressants
may enhance the risk of adverse effect of clobetasol propionate
It may enhance the effect when combined with irinotecan liposomal by affecting CYP3A4 metabolism
It may enhance the effect when combined with sufentanil by affecting CYP3A4 metabolism
may enhance myelosuppressive toxicity of pemetrexed
may enhance myelosuppressive toxicity of pralatrexate
when both drugs are combined, there may be an increased effect of cabozantinib by affecting hepatic or intestinal enzyme cyp3a4 metabolism
when both drugs are combined, there may be an increased effect of abemaciclib by affecting hepatic or intestinal enzyme CYP3A4 metabolism
when both drugs are combined, there may be a reduced metabolism of erlotinib
the effect of chloramphenicol is increased by lorlatinib, by altering intestinal or hepatic CYP3A4 enzyme metabolism. the effect of carbamazepine is decreased by lorlatinib, by altering intestinal or hepatic CYP3A4 enzyme metabolism
may increase the serum levels and effects of docetaxel
chloramphenicol increases the effect of lapatinib by altering the intestinal or hepatic CYP3A4 enzyme metabolism
when both drugs are combined, there may be an increase in the QTC interval
it will increase the impact or level of regorafenib by altering the intestinal or hepatic CYP3A4 enzyme metabolism
it increases the effect or level of ruxolitinib by altering the intestinal or hepatic CYP3A4 enzyme metabolism
may increase the level by affecting the hepatic enzyme CYP3A4 metabolism
may have an increased adverse effect when comb
may have an increased adverse effect when comb
may have an increased adverse effect when comb
may have an increased adverse effect when comb
may have an increased adverse effect when comb
chloramphenicol: they may decrease the therapeutic effect of Vitamin B12
It may enhance the levels when combined with tamsulosin by affecting CYP3A4 metabolism
it may diminish the metabolism when combined with formoterol
chloramphenicol: they may increase the toxic effect of myelosuppressive agents
It may enhance the risk of adverse reactions when combined with Ethylenimine
It may enhance the risk of adverse reactions when combined with Ethylenimine
piperacillin decreases the effectiveness of chloramphenicol by altering intestinal flora.
When penicillin G benzathine combines with chloramphenicol, the action and effectiveness of penicillin G benzathine decreases.
may enhance the adverse effects of bone marrow suppression
when both drugs are combined, there may be a high metabolism of vincristine
when both drugs are combined, there may be a decreased metabolism of paclitaxel
when both drugs are combined, there may be an increased risk or severity of adverse effects
when both drugs are combined, there may be an increased risk or severity of adverse effects
may enhance the adverse myelosuppressive effects of chloramphenicol
may enhance the adverse myelosuppressive effects of chloramphenicol
when both drugs are combined, there may be an increased risk or severity of adverse effects
may enhance adverse toxic effects of myelosuppressive agents
may enhance bone marrow suppression
may increase myelosuppressive effects
When both drugs are combined, there may be an increased risk of adverse effects
when both drugs are combined, there may be a reduced effect of ceftriaxone by pharmacodynamic antagonism ceftri
when both drugs are combined, there may be an increase in adverse/toxic effects of bone marrow suppression
it may increase the adverse effects such as bone marrow suppression activity floxu
it enhances the toxic effect of myelosuppressive agents
when both drugs are combined, there may be an increase in the adverse or toxic effects of myelosuppressive agents
it may increase the toxic or adverse effect of myelosuppressive agents
it increases the toxic/adverse effect of myelosuppressive drugs
may enhance bone marrow suppression
it increases by affecting the hepatic enzyme CYP3A4 metabolism
may increase the toxic effect of myelosuppressive agents
may increase the toxic effect of myelosuppressive agents
may increase the adverse effect of Myelosuppressive Agents
may increase the adverse effect of Myelosuppressive Agents
choline magnesium trisalicylate
It may enhance the risk of adverse reactions when combined with Salicylates
when both drugs are combined, there may be an increased risk of adverse effects
the interaction reduces the effects of cefprozil
the interaction reduces the effects of cefaclor
when both drugs are combined, there may be an increased risk of adverse effects
the interaction reduces the effects of cefepime
the interaction reduces the effects of cefuroxime
lansoprazole amoxicillin and clarithromycin
when amoxicillin combines with chloramphenicol it decreases the effects of the action of drug by antagonism effect
amoxicillin and clavulanate potassium
when amoxicillin combines with chloramphenicol it decreases the effects of the action of drug by antagonism effect
omeprazole amoxicillin and clarithromycin
when amoxicillin combines with chloramphenicol, it decreases the effects of the action of the drug by antagonism effect
when amoxicillin combines with chloramphenicol, it decreases the effects of the action of the drug by antagonism effect
ADVERTISEMENT
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
USA – BOSTON
60 Roberts Drive, Suite 313
North Adams, MA 01247
INDIA – PUNE
7, Shree Krishna, 2nd Floor, Opp Kiosk Koffee, Shirole Lane, Off FC Road, Pune 411004, Maharashtra
